Next steps in cell therapy manufacturing

Tuesday, March 19, 2024 at 10:10 AM to 10:30 AM · 20 min. (Europe/London)
Keynote [Track 1]
Presentation

Information

 

  • Spotlight on the complexities of CGT manufacturing
  • Addressing these complexities by standardizing the path to successful commercialization
  • Innovation and platforms to make CGT more accessible today and tomorrow
Lonza
30
Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our Cell & Gene offering spans across development and manufacturing services, products, solutions, testing and automation platforms as well as tools and technologies to enable you to develop, de-risk and industrialize your therapy, from basic research to commercialization.  

Registered attendees

Alexandra Harrison
Alexandra Harrison
PhD StudentUniversity of Bristol
Anna Louisa Weltin
Anna Louisa Weltin
Research FellowFraunhofer IPT
Ben Weil
Ben Weil
Chief Operating Officer & Chief Manufacturing OfficerINmuneBio

Log in

See all the content and easy-to-use features by logging in or registering!